Schrödinger, Inc.

NASDAQ:SDGR

Medical - Healthcare Information Services

Healthcare
$27.20 +0.01%

+$0.00 today

Market cap
$1.79B
Beta
1.64
P/E (TTM)
-11.1
EPS (TTM)
-$1.40
52W Low $10.95High $23.75

Volume 1.18M

Average 1.35M

SDGR Deferred Revenue (Non-current)

Payments received for goods or services the company will deliver after more than one year.

Schrödinger, Inc.NASDAQ: SDGR

Deferred Revenue (Non-current) · Q3 FY2026 · quarter ended Sep 2026

Deferred revenue (non-current) remains negative

Q3 FY2026 deferred revenue (non-current) was $0, compared with $92.39M a year earlier. Over 3 fiscal years it compounded at +45.5% a year.

Context

  • Deferred revenue (non-current) amounted to 0.0% of total assets at the end of Q3 FY2026, down 14.1 pp from a year earlier.
  • Deferred revenue (non-current) increased in 1 of the last 3 fiscal years.

What to watch

Whether deferred revenue (non-current) keeps falling in the next quarterly balance sheet after a -100.0% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2026
$0-100.0% QoQ
Last fiscal yearDec 2025
$78.88M-27.5% YoY
Year agoSep 2025
$92.39M-100.0% since
Deferred Revenue (Non-current) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-100.0%——
1 year-27.5%——
3-year CAGR+45.5%——
5-year CAGR——
10-year CAGR——

Deferred Revenue (Non-current) history

USD · from the balance sheet

Latest · FY2025
78.88M USD
Year-over-year change
-27.5%
4-year CAGR
+27.3%

Deferred Revenue (Non-current) vs competitors

How SDGR compares with its peers on the latest reported figures

  • Peers report in different currencies, so deferred revenue (non-current) is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -100.0% is the lowest of 3, against a peer median of +35.1%.
  • Deferred revenue (non-current) amounts to 0.0% of total assets for SDGR, versus a peer median of 0.0%.
SDGR Competitors
Deferred Revenue (Non-current) for SDGR and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ABCLAbCellera Biologics Inc.Sep 2026$48.05M USD-72.5%+42.5%3.2%
CERTCertara, Inc.Mar 2026$3.1M USD+142.8%—0.2%
GENBGenerate Biomedicines, Inc.Mar 2026$1.24M USD——0.2%
SDGRSchrödinger, Inc.Sep 2026$0 USD-100.0%+45.5%0.0%
VEEVVeeva Systems Inc.Jul 2026$0 USD——0.0%
RLAYRelay Therapeutics, Inc.Jun 2026$0 USD——0.0%
SLPSimulations Plus, Inc.Feb 2026$0 USD——0.0%
HYFTMindWalk Holdings Corp.Jan 2026CA$0 CAD——0.0%
LTRNLantern Pharma Inc.Mar 2026$0 USD——0.0%
Peer median (excluding SDGR) —+35.1%+42.5%0.0%

Competitors are the stored peer set for SDGR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents120.27M90.47M155.32M147.33M230.52M
Short-term Investments456.21M360.61M307.69M204.8M164.95M
Net Receivables40.55M69.09M89.12M255.33M104.39M
Inventory00000
Other Current Assets3M5.24M5.75M15.33M6.87M
Total Current Assets625.06M533.99M567.8M634.99M519.27M
Property, Plant & Equipment (Net)85.41M120.23M141.1M136.08M122.19M
Goodwill04.79M4.79M4.79M4.79M
Intangible Assets0587K000
Long-term Investments43.17M25.68M83.25M43.21M73.65M
Tax Assets00000
Other Non-current Assets2.85M3.31M6.01M4.16M6.27M
Total Non-current Assets131.43M154.6M235.16M188.23M206.9M
Total Assets756.49M688.59M802.96M823.23M726.16M
Account Payables8.08M9.47M16.82M10.67M11.45M
Short-term Debt000016.41M
Tax Payables00000
Deferred Revenue55.37M57.93M56.23M111.94M112.85M
Other Current Liabilities000048.42M
Total Current Liabilities91.21M108.8M133.67M191.75M189.14M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)30.06M25.6M9.04M108.81M78.88M
Other Non-current Liabilities300K800K667K146K1.28M
Total Non-current Liabilities108.19M131.88M120.72M210.03M172.97M
Total Liabilities199.4M240.68M254.4M401.78M362.11M
Common Stock710K714K722K729K645K
Retained Earnings(229.95M)(379.14M)(338.42M)(525.54M)(628.81M)
Accumulated OCI(651K)(2.38M)281K220K107K
Other Stockholders Equity00000
Minority Interest14K11K000
Total Equity557.09M447.91M548.56M421.45M364.05M
Total Debt79.87M116.49M127.88M117.83M109.23M
Net Debt(40.4M)26.02M(27.43M)(29.5M)(121.29M)

Schrödinger, Inc.

NASDAQ:SDGR

Intrinsic Alpha fair value

Locked

Current Price

$27.20

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.